Prostate radiotherapy for men with metastatic disease: a new comparison in the systemic therapy in advancing or metastatic prostate cancer: evaluation of drug efficacy (STAMPEDE) trial.
Authors
Parker, CSydes, M
Mason, M
Clarke, Noel W
Aebersold, D
de Bono, J
Dearnaley, D
Ritchie, A
Russell, J
Thalmann, G
Parmar, M
James, N
Affiliation
Institute of Cancer Research and Royal Marsden Hospitals Foundation Trust, Sutton, UK.Issue Date
2013-05
Metadata
Show full item recordCitation
Prostate radiotherapy for men with metastatic disease: a new comparison in the systemic therapy in advancing or metastatic prostate cancer: evaluation of drug efficacy (STAMPEDE) trial. 2013, 111 (5):697-9 BJU IntJournal
BJU InternationalDOI
10.1111/bju.12087PubMed ID
23578233Type
ArticleLanguage
enISSN
1464-410Xae974a485f413a2113503eed53cd6c53
10.1111/bju.12087
Scopus Count
Collections
Related articles
- STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial.
- Authors: James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Anderson J, Popert RJ, Sanders K, Morgan RC, Stansfeld J, Dwyer J, Masters J, Parmar MK
- Issue date: 2008 Oct
- Should docetaxel be administered earlier in prostate cancer therapy?
- Authors: Graff JN, Beer TM
- Issue date: 2015
- STAMPEDE: Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer?
- Authors: Choudhury A, Chen RC, Henry A, Mistry H, Mitin T, Pinkawa M, Spratt DE
- Issue date: 2019 May 1
- The evolving options in metastatic castration-sensitive prostate cancer.
- Authors: Hamilou Z
- Issue date: 2020 Sep
- Prostate radiotherapy in newly diagnosed metastatic prostate cancer.
- Authors: Ali A, Parker CC, Clarke NW
- Issue date: 2019 Nov